107 related articles for article (PubMed ID: 17365652)
1. Induction of a high affinity fibronectin receptor in Candida albicans by caspofungin: requirements for beta (1,6) glucans and the developmental regulator Hbr1p.
Pendrak ML; Rodrigues RG; Roberts DD
Med Mycol; 2007 Mar; 45(2):157-68. PubMed ID: 17365652
[TBL] [Abstract][Full Text] [Related]
2. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
3. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
4. Studies of the paradoxical effect of caspofungin at high drug concentrations.
Stevens DA; White TC; Perlin DS; Selitrennikoff CP
Diagn Microbiol Infect Dis; 2005 Mar; 51(3):173-8. PubMed ID: 15766602
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
6. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
Angiolella L; Simonetti N; Cassone A
J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
[TBL] [Abstract][Full Text] [Related]
7. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins.
Soustre J; Rodier MH; Imbert-Bouyer S; Daniault G; Imbert C
J Antimicrob Chemother; 2004 Mar; 53(3):522-5. PubMed ID: 14749343
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
10. Efg1 Controls caspofungin-induced cell aggregation of Candida albicans through the adhesin Als1.
Gregori C; Glaser W; Frohner IE; Reinoso-Martín C; Rupp S; Schüller C; Kuchler K
Eukaryot Cell; 2011 Dec; 10(12):1694-704. PubMed ID: 22037180
[TBL] [Abstract][Full Text] [Related]
11. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic.
Angiolella L; Maras B; Stringaro AR; Arancia G; Mondello F; Girolamo A; Palamara AT; Cassone A
J Chemother; 2005 Aug; 17(4):409-16. PubMed ID: 16167521
[TBL] [Abstract][Full Text] [Related]
12. Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin.
Badrane H; Nguyen MH; Blankenship JR; Cheng S; Hao B; Mitchell AP; Clancy CJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4614-24. PubMed ID: 22687514
[TBL] [Abstract][Full Text] [Related]
13. Cell wall integrity is linked to mitochondria and phospholipid homeostasis in Candida albicans through the activity of the post-transcriptional regulator Ccr4-Pop2.
Dagley MJ; Gentle IE; Beilharz TH; Pettolino FA; Djordjevic JT; Lo TL; Uwamahoro N; Rupasinghe T; Tull DL; McConville M; Beaurepaire C; Nantel A; Lithgow T; Mitchell AP; Traven A
Mol Microbiol; 2011 Feb; 79(4):968-89. PubMed ID: 21299651
[TBL] [Abstract][Full Text] [Related]
14. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
Copping VM; Barelle CJ; Hube B; Gow NA; Brown AJ; Odds FC
J Antimicrob Chemother; 2005 May; 55(5):645-54. PubMed ID: 15820985
[TBL] [Abstract][Full Text] [Related]
15. A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes.
Drakulovski P; Dunyach C; Bertout S; Reynes J; Mallié M
Med Mycol; 2011 Jul; 49(5):467-74. PubMed ID: 21108572
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
[TBL] [Abstract][Full Text] [Related]
17. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
18. Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.
Verwer PE; van Duijn ML; Tavakol M; Bakker-Woudenberg IA; van de Sande WW
Antimicrob Agents Chemother; 2012 Mar; 56(3):1595-8. PubMed ID: 22203603
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Liu TT; Lee RE; Barker KS; Lee RE; Wei L; Homayouni R; Rogers PD
Antimicrob Agents Chemother; 2005 Jun; 49(6):2226-36. PubMed ID: 15917516
[TBL] [Abstract][Full Text] [Related]
20. A drug-sensitive genetic network masks fungi from the immune system.
Wheeler RT; Fink GR
PLoS Pathog; 2006 Apr; 2(4):e35. PubMed ID: 16652171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
